Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2020-03-27

Restrictions in use of cyproterone due to meningioma risk

View source ↗

Summary

The EMA restricted the use of cyproterone due to an increased risk of meningioma, outlining limitations on indications and duration of use and recommending alte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyproterone (cyproterone acetate)